Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-09-19 Purchase | 2023-09-19 9:47 pm | Neumora Therapeutics Inc. | NMRA | Gosebruch Henry O President & CEO | 15,000 | $12.62 | $189,371 | 524,793 (Indirect Direct) | View |
| 2023-05-09 Purchase | 2023-05-11 9:06 pm | ACELYRIN Inc. | SLRN | Gosebruch Henry O Director | 50,000 | $18 | $900,000 | 205,450 (Direct) | View |
| 2022-05-16 Sale(A) | 2022-05-20 5:03 pm | AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer | 83,960 | $155 | $13,013,800 | 98,761 (Indirect Direct) | View |
| 2022-03-01 Sale(A) | 2022-05-20 5:00 pm | AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer | 25,000 | $147.29 | $3,682,189 | 98,580 (Indirect Direct) | View |
| 2022-05-16 Sale | 2022-05-18 5:12 pm | AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer | 83,960 | $155 | $13,013,800 | 98,580 (Indirect Direct) | View |
| 2022-03-01 Sale | 2022-03-02 5:03 pm | AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer | 25,000 | $147.29 | $3,682,189 | 98,580 (Indirect Direct) | View |
| 2022-03-01 Sale | 2022-03-01 6:14 pm | AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer | 15,000 | $148.26 | $2,223,836 | 123,580 (Indirect Direct) | View |
| 2020-11-20 Sale | 2020-11-24 5:34 pm | AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer | 40,000 | $99.38 | $3,975,046 | 71,370 (Indirect Direct) | View |
| 2020-01-10 Purchase | 2020-01-14 4:19 pm | Aptinyx Inc. | APTX | Gosebruch Henry O Director | 25,000 | $3 | $75,000 | 125,000 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-07 Option Award | 2024-06-11 7:11 pm | N/A 2034-06-06 | ACELYRIN Inc. | SLRN | Gosebruch Henry O Director | 92,158 | $0 | 92,158 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 4:15 pm | N/A 2034-02-13 | Neumora Therapeutics Inc. | NMRA | Gosebruch Henry O President & CEO | 240,000 | $0 | 764,793 (Direct) | View |
Ownership | 2023-09-14 6:58 pm | N/A N/A | Neumora Therapeutics Inc. | NMRA | Gosebruch Henry O President & CEO | 0 | $0 | 2,548,970 (Direct) | View |
| 2023-05-09 Other | 2023-05-11 9:06 pm | N/A 2033-03-22 | ACELYRIN Inc. | SLRN | Gosebruch Henry O Director | 310,900 | $0 | 205,450 (Direct) | View |
Ownership | 2023-05-04 7:46 pm | N/A 2033-03-22 | ACELYRIN Inc. | SLRN | Gosebruch Henry O Director | 0 | $0 | 155,450 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-31 4:31 pm | N/A 2032-05-25 | Aptinyx Inc. | APTX | Gosebruch Henry O Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-05-16 Exercise(A) | 2022-05-20 5:03 pm | 2017-02-18 2026-02-17 | AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer | 83,960 | $54.86 | 98,761 (Direct) | View |
| 2022-05-16 Exercise | 2022-05-18 5:12 pm | 2017-02-18 2026-02-17 | AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer | 83,960 | $54.86 | 98,580 (Direct) | View |
| 2022-02-25 Tax Withholding | 2022-03-01 6:14 pm | N/A N/A | AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer | 30,156 | $149.54 | 123,580 (Direct) | View |
| 2022-02-17 Option Award | 2022-02-22 5:39 pm | 2023-02-17 2032-02-16 | AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer | 98,715 | $0 | 199,383 (Direct) | View |
| 2021-09-07 Gift | 2021-09-10 5:01 pm | N/A N/A | AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer | 30,000 | $0 | 100,500 (Direct) | View |
| 2021-05-27 Option Award | 2021-06-01 4:36 pm | N/A 2031-05-26 | Aptinyx Inc. | APTX | Gosebruch Henry O Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-02-28 Tax Withholding | 2021-03-02 8:34 pm | N/A N/A | AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer | 22,833 | $107.74 | 100,355 (Direct) | View |
| 2021-02-18 Option Award | 2021-02-22 6:25 pm | 2022-02-18 2031-02-17 | AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer | 100,606 | $0 | 171,976 (Direct) | View |
| 2020-12-31 Option Award | 2021-01-05 4:31 pm | N/A 2030-12-30 | Aptinyx Inc. | APTX | Gosebruch Henry O Director | 5,339 | $2.224 | 5,339 (Direct) | View |
| 2020-09-30 Option Award | 2020-10-02 3:05 pm | N/A 2030-09-29 | Aptinyx Inc. | APTX | Gosebruch Henry O Director | 5,490 | $2.163 | 5,490 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-02 4:06 pm | N/A 2030-06-29 | Aptinyx Inc. | APTX | Gosebruch Henry O Director | 4,051 | $2.677 | 4,051 (Direct) | View |
| 2020-05-20 Option Award | 2020-05-22 4:11 pm | N/A 2030-05-19 | Aptinyx Inc. | APTX | Gosebruch Henry O Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2020-04-06 Gift | 2020-04-24 5:10 pm | N/A N/A | AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer | 18,500 | $0 | 111,268 (Direct) | View |
| 2020-03-31 Option Award | 2020-04-02 4:24 pm | N/A 2030-03-30 | Aptinyx Inc. | APTX | Gosebruch Henry O Director | 7,374 | $1.356 | 7,374 (Direct) | View |
| 2020-02-28 Tax Withholding | 2020-03-03 4:53 pm | N/A N/A | AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer | 26,038 | $85.42 | 110,782 (Direct) | View |
| 2020-02-20 Option Award | 2020-02-24 6:02 pm | 2021-02-20 2030-02-19 | AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer | 155,344 | $0 | 233,383 (Direct) | View |
| 2019-12-31 Option Award | 2020-01-03 4:24 pm | N/A 2029-12-30 | Aptinyx Inc. | APTX | Gosebruch Henry O Director | 4,668 | $2.142 | 4,668 (Direct) | View |